Resveratrol-loaded liposomes for topical treatment of the vaginal inflammation and infections

European Journal of Pharmaceutical Sciences

Volumn 79, Issue , 2015, Pages 112-121

  Jøraholmen, May Wenche ^a   Škalko Basnet, Nataša ^a   Acharya, Ganesh ^b,c   Basnet, Purusotam ^b,c  

^a Faculty of Health Sciences   (Norway)

^b UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^c Women's Health and Perinatology Research Group Department of Clinical Medicine   (Norway)

Author keywords

3 5 4 Trihydroxy trans stilbene; Anti inflammatory; Anti oxidant; Liposomes; Mucoadhesive; Resveratrol; Vaginal infections

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; 2,2' AZINOBIS(3 ETHYLBENZOTHIAZOLINE 6 SULFONIC ACID); ALPHA TOCOPHEROL; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; ASCORBIC ACID; CHITOSAN; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; LIPOSOME; NITRIC OXIDE; RESVERATROL; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA; NONSTEROID ANTIINFLAMMATORY AGENT; STILBENE DERIVATIVE;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; COATED VESICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG FORMULATION; ENZYME ACTIVITY; IN VITRO STUDY; LIPOSOMAL DELIVERY; NONHUMAN; PRIORITY JOURNAL; STANDARD; SUSTAINED DRUG RELEASE; THERAPY EFFECT; TOPICAL TREATMENT; VULVOVAGINITIS; ANIMAL; CELL LINE; FEMALE; INTRAVAGINAL DRUG ADMINISTRATION; METABOLISM; MOUSE; VAGINITIS; VAGINOSIS, BACTERIAL;

ADMINISTRATION, INTRAVAGINAL; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIOXIDANTS; CELL LINE; FEMALE; INTERLEUKIN-1BETA; LIPOSOMES; MICE; STILBENES; TUMOR NECROSIS FACTOR-ALPHA; VAGINITIS; VAGINOSIS, BACTERIAL;

EID: 84942237515     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2015.09.007     Document Type: Article

References (71)

1. A. Abbott, and G. Brumfiel Nobel for AIDS virus discovery, finally Nature 455 7214 2008 712 713 10.1038/455712a
2. M. Adrian, and P. Jeandet Effects of resveratrol on the ultrastructure of Botrytis cinerea conidia and biological significance in plant/pathogen interactions Fitoterapia 83 8 2012 1345 1350 10.1016/j.fitote.2012.04.004
3. I.B. Afanas'ev Signaling functions of free radicals superoxide & nitric oxide under physiological & pathological conditions Mol. Biotechnol. 37 2007 2 4
4. A. Amri, J.C. Chaumeil, S. Sfar, and C. Charrueau Administration of resveratrol: what formulation solutions to bioavailability limitations? J. Control. Release 158 2 2012 182 193 10.1016/j.jconrel.2011.09.083
5. A. Amri, S. Le Clanche, P. Therond, D. Bonnefont-Rousselot, D. Borderie, R. Lai-Kuen, J.C. Chaumeil, S. Sfar, and C. Charrueau Resveratrol self-emulsifying system increases the uptake by endothelial cells and improves protection against oxidative stress-mediated death Eur. J. Pharm. Biopharm. 86 3 2014 418 426 10.1016/j.ejpb.2013.10.015
6. T. Andersen, S. Bleher, G. Eide Flaten, I. Tho, S. Mattsson, and N. Skalko-Basnet Chitosan in mucoadhesive drug delivery: focus on local vaginal therapy Mar. Drugs 13 1 2015 222 236 10.3390/md13010222
7. M.A. Augustin, L. Sanguansri, and T. Lockett Nano- and micro-encapsulated systems for enhancing the delivery of resveratrol Ann. N. Y. Acad. Sci. 1290 2013 107 112 10.1111/nyas.12130
8. P. Basnet, H. Hussain, I. Tho, and N. Skalko-Basnet Liposomal delivery system enhances anti-inflammatory properties of curcumin J. Pharm. Sci. 101 2 2012 598 609 10.1002/jps.22785
9. J.A. Baur, and D.A. Sinclair Therapeutic potential of resveratrol: the in vivo evidence Nat. Rev. Drug Discov. 5 6 2006 493 506 10.1038/nrd2060
10. K.P.L. Bhat, J.W. Kosmeder, and J.M. Pezzuto Biological effects of resveratrol Antioxid. Redox Signal. 3 6 2001 1041 1064 10.1089/152308601317203567
11. C. Caddeo, K. Teskac, C. Sinico, and J. Kristl Effect of resveratrol incorporated in liposomes on proliferation and UV-B protection of cells Int. J. Pharm. 363 1-2 2008 183 191 10.1016/j.ijpharm.2008.07.024
12. C. Caddeo, M. Manconi, A.M. Fadda, F. Lai, S. Lampis, O. Diez-Sales, and C. Sinico Nanocarriers for antioxidant resveratrol: formulation approach, vesicle self-assembly and stability evaluation Colloids Surf. B: Biointerfaces 111 2013 327 332 10.1016/j.colsurfb.2013.06.016
13. P.G. Cadena, M.A. Pereira, R.B. Cordeiro, I.M. Cavalcanti, B. Barros Neto, C. Pimentel Mdo, J.L. Lima Filho, V.L. Silva, and N.S. Santos-Magalhaes Nanoencapsulation of quercetin and resveratrol into elastic liposomes Biochim. Biophys. Acta 1828 2 2013 309 316 10.1016/j.bbamem.2012.10.022
14. M.M. Chan Antimicrobial effect of resveratrol on dermatophytes and bacterial pathogens of the skin Biochem. Pharmacol. 63 2 2002 99 104
15. M. Coimbra, B. Isacchi, L. van Bloois, J.S. Torano, A. Ket, X. Wu, F. Broere, J.M. Metselaar, C.J. Rijcken, G. Storm, R. Bilia, and R.M. Schiffelers Improving solubility and chemical stability of natural compounds for medicinal use by incorporation into liposomes Int. J. Pharm. 416 2 2011 433 442 10.1016/j.ijpharm.2011.01.056
16. J.W. Coleman Nitric oxide in immunity and inflammation Int. Immunopharmacol. 1 8 2001 1397 1406
17. C.H. Cottart, V. Nivet-Antoine, C. Laguillier-Morizot, and J.L. Beaudeux Resveratrol bioavailability and toxicity in humans Mol. Nutr. Food Res. 54 1 2010 7 16 10.1002/mnfr.200900437
18. S.L. Cudmore, K.L. Delgaty, S.F. Hayward-McClelland, D.P. Petrin, and G.E. Garber Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis Clin. Microbiol. Rev. 17 4 2004 783 793 10.1128/CMR.17.4.783-793.2004
19. J. das Neves, M. Amiji, and B. Sarmento Mucoadhesive nanosystems for vaginal microbicide development: friend or foe? Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 3 4 2011 389 399 10.1002/wnan.144
20. J. das Neves, M.F. Bahia, M.M. Amiji, and B. Sarmento Mucoadhesive nanomedicines: characterization and modulation of mucoadhesion at the nanoscale Expert Opin. Drug Deliv. 8 8 2011 1085 1104 10.1517/17425247.2011.586334
21. S. Das, M. Huengsberg, and M. Shahmanesh Treatment failure of vaginal trichomoniasis in clinical practice Int. J. STD AIDS 16 4 2005 284 286 10.1258/0956462053654258
22. S. Das, H.S. Lin, P.C. Ho, and K.Y. Ng The impact of aqueous solubility and dose on the pharmacokinetic profiles of resveratrol Pharm. Res. 25 11 2008 2593 2600 10.1007/s11095-008-9677-1
23. C.A. de la Lastra, and I. Villegas Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implications Biochem. Soc. Trans. 35 Pt 5 2007 1156 1160 10.1042/BST0351156
24. C.A. Dinarello Proinflammatory cytokines Chest 118 2 2000 503 508
25. J.J. Docherty, M.M. Fu, J.M. Hah, T.J. Sweet, S.A. Faith, and T. Booth Effect of resveratrol on herpes simplex virus vaginal infection in the mouse Antivir. Res. 67 3 2005 155 162 10.1016/j.antiviral.2005.06.008
26. S.A. Faith, T.J. Sweet, E. Bailey, T. Booth, and J.J. Docherty Resveratrol suppresses nuclear factor-kappaB in herpes simplex virus infected cells Antivir. Res. 72 3 2006 242 251 10.1016/j.antiviral.2006.06.011
27. T. Finkel, and N.J. Holbrook Oxidants, oxidative stress and the biology of ageing Nature 408 6809 2000 239 247 10.1038/35041687
28. G. Fricker, T. Kromp, A. Wendel, A. Blume, J. Zirkel, H. Rebmann, C. Setzer, R.O. Quinkert, F. Martin, and C. Muller-Goymann Phospholipids and lipid-based formulations in oral drug delivery Pharm. Res. 27 8 2010 1469 1486 10.1007/s11095-010-0130-x
29. S.P. Garcia-Zepeda, E. Garcia-Villa, J. Diaz-Chavez, R. Hernandez-Pando, and P. Gariglio Resveratrol induces cell death in cervical cancer cells through apoptosis and autophagy Eur. J. Cancer Prev. 22 6 2013 577 584 10.1097/CEJ.0b013e328360345f
30. E.H. Gokce, E. Korkmaz, E. Dellera, G. Sandri, M.C. Bonferoni, and O. Ozer Resveratrol-loaded solid lipid nanoparticles versus nanostructured lipid carriers: evaluation of antioxidant potential for dermal applications Int. J. Nanomedicine 7 2012 1841 1850 10.2147/IJN.S29710
31. I. Gülçin Antioxidant properties of resveratrol: a structure-activity insight Innovative Food Sci. Emerg. Technol. 11 1 2010 210 218 10.1016/j.ifset.2009.07.002
32. J. Guo, Q. Ping, G. Jiang, L. Huang, and Y. Tong Chitosan-coated liposomes: characterization and interaction with leuprolide Int. J. Pharm. 260 2 2003 167 173
33. D. Hanahan, and R.A. Weinberg The hallmarks of cancer Cell 100 1 2000 57 70
34. D.F. Harp, and I. Chowdhury Trichomoniasis: evaluation to execution Eur. J. Obstet. Gynecol. Reprod. Biol. 157 1 2011 3 9 10.1016/j.ejogrb.2011.02.024
35. B. Houille, N. Papon, L. Boudesocque, E. Bourdeaud, S. Besseau, V. Courdavault, C. Enguehard-Gueiffier, G. Delanoue, L. Guerin, J.P. Bouchara, M. Clastre, N. Giglioli-Guivarc'h, J. Guillard, and A. Lanoue Antifungal activity of resveratrol derivatives against Candida species J. Nat. Prod. 77 7 2014 1658 1662 10.1021/np5002576
36. M. Jang, L. Cai, G.O. Udeani, K.V. Slowing, C.F. Thomas, C.W. Beecher, H.H. Fong, N.R. Farnsworth, A.D. Kinghorn, R.G. Mehta, R.C. Moon, and J.M. Pezzuto Cancer chemopreventive activity of resveratrol, a natural product derived from grapes Science 275 5297 1997 218 220
37. M.W. Jøraholmen, Z. Vanic, I. Tho, and N. Skalko-Basnet Chitosan-coated liposomes for topical vaginal therapy: assuring localized drug effect Int. J. Pharm. 472 1-2 2014 94 101 10.1016/j.ijpharm.2014.06.016
38. K.H. Jung, J.H. Lee, J.W. Park, C.H. Quach, S.H. Moon, Y.S. Cho, and K.H. Lee Resveratrol-loaded polymeric nanoparticles suppress glucose metabolism and tumor growth in vitro and in vivo Int. J. Pharm. 478 1 2014 251 257 10.1016/j.ijpharm.2014.11.049
39. K.K. Kandimalla, E. Borden, R.S. Omtri, S.P. Boyapati, M. Smith, K. Lebby, M. Mulpuru, and M. Gadde Ability of chitosan gels to disrupt bacterial biofilms and their applications in the treatment of bacterial vaginosis J. Pharm. Sci. 102 7 2013 2096 2101 10.1002/jps.23571
40. N. Khan, F. Afaq, and H. Mukhtar Cancer chemoprevention through dietary antioxidants: progress and promise Antioxid. Redox Signal. 10 3 2008 475 510 10.1089/ars.2007.1740
41. K.W. Kim, R.L. Thomas, C. Lee, and H.J. Park Antimicrobial activity of native chitosan, degraded chitosan, and O-carboxymethylated chitosan J. Food Prot. 66 8 2003 1495 1498
42. J. Kristl, K. Teskac, C. Caddeo, Z. Abramovic, and M. Sentjurc Improvements of cellular stress response on resveratrol in liposomes Eur. J. Pharm. Biopharm. 73 2 2009 253 259 10.1016/j.ejpb.2009.06.006
43. N. Li, C. Zhuang, M. Wang, X. Sun, S. Nie, and W. Pan Liposome coated with low molecular weight chitosan and its potential use in ocular drug delivery Int. J. Pharm. 379 1 2009 131 138 10.1016/j.ijpharm.2009.06.020
44. X. Lu, C. Ji, H. Xu, X. Li, H. Ding, M. Ye, Z. Zhu, D. Ding, X. Jiang, X. Ding, and X. Guo Resveratrol-loaded polymeric micelles protect cells from Abeta-induced oxidative stress Int. J. Pharm. 375 1-2 2009 89 96 10.1016/j.ijpharm.2009.03.021
45. X. Lu, H. Xu, B. Sun, Z. Zhu, D. Zheng, and X. Li Enhanced neuroprotective effects of resveratrol delivered by nanoparticles on hydrogen peroxide-induced oxidative stress in rat cortical cell culture Mol. Pharm. 10 5 2013 2045 2053 10.1021/mp400056c
46. N. Mallo, J. Lamas, and J.M. Leiro Hydrogenosome metabolism is the key target for antiparasitic activity of resveratrol against Trichomonas vaginalis Antimicrob. Agents Chemother. 57 6 2013 2476 2484 10.1128/AAC.00009-13
47. J. Meng, T.F. Sturgis, and B.B. Youan Engineering tenofovir loaded chitosan nanoparticles to maximize microbicide mucoadhesion Eur. J. Pharm. Sci. 44 1-2 2011 57 67 10.1016/j.ejps.2011.06.007
48. C. Muzny, A. Barnes, and L. Mena Symptomatic Trichomonas vaginalis infection in the setting of severe nitroimidazole allergy: successful treatment with boric acid Sex. Health 9 4 2012 389 391 10.1071/SH11114
49. E. Naderkhani, A. Erber, N. Skalko-Basnet, and G. Eide Flaten Improved permeability of acyclovir: optimization of mucoadhesive liposomes using the phospholipid vesicle-based permeation assay J. Pharm. Sci. 103 2 2014 661 668 10.1002/jps.23845
50. E.M. Nawrocki, H.W. Bedell, and T.L. Humphreys Resveratrol is cidal to both classes of Haemophilus ducreyi Int. J. Antimicrob. Agents 41 5 2013 477 479 10.1016/j.ijantimicag.2013.02.008
51. D.S. Nikolic, and V. Piguet Vaccines and microbicides preventing HIV-1, HSV-2, and HPV mucosal transmission J. Invest. Dermatol. 130 2 2010 352 361 10.1038/jid.2009.227
52. R. Pangeni, J.K. Sahni, J. Ali, S. Sharma, and S. Baboota Resveratrol: review on therapeutic potential and recent advances in drug delivery Expert Opin. Drug Deliv. 11 8 2014 1285 1298 10.1517/17425247.2014.919253
53. S.N. Park, N.R. Jo, and S.H. Jeon Chitosan-coated liposomes for enhanced skin permeation of resveratrol J. Ind. Eng. Chem. 20 2014 1481 1485 10.1016/j.jiec.2013.07.035
54. Z. Pavelic, N. Skalko-Basnet, and I. Jalsenjak Liposomes containing drugs for treatment of vaginal infections Eur. J. Pharm. Sci. 8 4 1999 345 351
55. Z. Pavelic, N. Skalko-Basnet, J. Filipovic-Grcic, A. Martinac, and I. Jalsenjak Development and in vitro evaluation of a liposomal vaginal delivery system for acyclovir J. Control. Release 106 1-2 2005 34 43 10.1016/j.jconrel.2005.03.032
56. Z. Pavelic, N. Skalko-Basnet, and I. Jalsenjak Characterisation and in vitro evaluation of bioadheshive liposome gels for local therapy of vaginitis Int. J. Pharm. 301 2005 140 148 10.1016/j.jjpharm.2005.05.022
57. M.G. Santoro, A. Rossi, and C. Amici NF-kappaB and virus infection: who controls whom EMBO J. 22 11 2003 2552 2560 10.1093/emboj/cdg267
58. I. Scognamiglio, D. De Stefano, V. Campani, L. Mayol, R. Carnuccio, G. Fabbrocini, F. Ayala, M.I. La Rotonda, and G. De Rosa Nanocarriers for topical administration of resveratrol: a comparative study Int. J. Pharm. 440 2 2013 179 187 10.1016/j.ijpharm.2012.08.009
59. G. Singh, and R.S. Pai Recent advances of resveratrol in nanostructured based delivery systems and in the management of HIV/AIDS J. Control. Release 194 2014 178 188 10.1016/j.jconrel.2014.09.002
60. J.M. Smoliga, J.A. Baur, and H.A. Hausenblas Resveratrol and health - a comprehensive review of human clinical trials Mol. Nutr. Food Res. 55 8 2011 1129 1141 10.1002/mnfr.201100143
61. S. Stojanovic, H. Sprinz, and O. Brede Efficiency and mechanism of the antioxidant action of trans-resveratrol and its analogues in the radical liposome oxidation Arch. Biochem. Biophys. 391 1 2001 79 89 10.1006/abbi.2001.2388
62. K. Subbaramaiah, W.J. Chung, P. Michaluart, N. Telang, T. Tanabe, H. Inoue, M. Jang, J.M. Pezzuto, and A.J. Dannenberg Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells J. Biol. Chem. 273 34 1998 21875 21882
63. Y.J. Surh, and H.K. Na NF-kappaB and Nrf2 as prime molecular targets for chemoprevention and cytoprotection with anti-inflammatory and antioxidant phytochemicals Genes Nutr. 2 4 2008 313 317 10.1007/s12263-007-0063-0
64. H. Takeuchi, H. Yamamoto, and Y. Kawashima Mucoadhesive nanoparticulate systems for peptide drug delivery Adv. Drug Deliv. Rev. 47 1 2001 39 54
65. K. Teskac, and J. Kristl The evidence for solid lipid nanoparticles mediated cell uptake of resveratrol Int. J. Pharm. 390 1 2010 61 69 10.1016/j.ijpharm.2009.10.011
66. C. Valenta The use of mucoadhesive polymers in vaginal delivery Adv. Drug Deliv. Rev. 57 11 2005 1692 1712 10.1016/j.addr.2005.07.004
67. J.H. van de Wijgert, and R.J. Shattock Vaginal microbicides: moving ahead after an unexpected setback AIDS 21 18 2007 2369 2376 10.1097/QAD.0b013e3282ef83fd
68. K. Vanaja, M.A. Wahl, L. Bukarica, and H. Heinle Liposomes as carriers of the lipid soluble antioxidant resveratrol: evaluation of amelioration of oxidative stress by additional antioxidant vitamin Life Sci. 93 24 2013 917 923 10.1016/j.lfs.2013.10.019
69. O. Vang, N. Ahmad, C.A. Baile, J.A. Baur, K. Brown, A. Csiszar, D.K. Das, D. Delmas, C. Gottfried, H.Y. Lin, Q.Y. Ma, P. Mukhopadhyay, N. Nalini, J.M. Pezzuto, T. Richard, Y. Shukla, Y.J. Surh, T. Szekeres, T. Szkudelski, T. Walle, and J.M. Wu What is new for an old molecule? Systematic review and recommendations on the use of resveratrol PLoS One 6 6 2011 e19881 10.1371/journal.pone.0019881
70. Z. Vanic, and N. Skalko-Basnet Nanopharmaceuticals for improved topical vaginal therapy: can they deliver? Eur. J. Pharm. Sci. 50 1 2013 29 41 10.1016/j.ejps.2013.04.035
71. Y. Zheng, Y. Liu, J. Ge, X. Wang, L. Liu, Z. Bu, and P. Liu Resveratrol protects human lens epithelial cells against H2O2-induced oxidative stress by increasing catalase, SOD-1, and HO-1 expression Mol. Vis. 16 2010 1467 1474